Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
PLoS Negl Trop Dis ; 15(12): e0010007, 2021 12.
Article in English | MEDLINE | ID: mdl-34932554

ABSTRACT

Glanders is a highly contagious and potentially serious disease caused by Burkholderia mallei, a Tier 1 select agent. In this study, we raised a monoclonal antibody (mAb) against the lipopolysaccharide (LPS) of B. mallei and developed a competitive enzyme-linked immunosorbent assay (cELISA) for B. mallei infection. Using the titrated optimal conditions of B. mallei-LPS (2 ng) for microtiter plate coating, sample serum dilution at 1:20 and 3.5 ng/µL anti-LPS mAb B5, the cutoff value of the cELISA was determined using serum samples from 136 glanders-free seronegative horses in Hong Kong. All calculated percentage inhibition (PI) values from these seronegative samples were below 39.6% inhibition (1.5 standard deviations above mean PI) and was used as the cutoff value. The diagnostic sensitivity of the developed LPS-based cELISA was first evaluated using sera from donkeys and mice inoculated with B. mallei. An increasing trend of PI values above the defined cELISA cutoff observed in the donkey and mouse sera suggested positive detection of anti-LPS antibodies. The sensitivity and specificity of the LPS-based cELISA was further evaluated using 31 serologically positive horse sera from glanders outbreaks in Bahrain and Kuwait, of which 30 were tested positive by the cELISA; and 21 seronegative horse sera and 20 seronegative donkey sera from Dubai, of which all were tested negative by the cELISA. A cELISA with high sensitivity (97.2%) and specificity (100%) for the detection of B. mallei antibodies in different animals was developed.


Subject(s)
Burkholderia mallei/isolation & purification , Enzyme-Linked Immunosorbent Assay/methods , Glanders/diagnosis , Horse Diseases/diagnosis , Serologic Tests/methods , Animals , Antibodies, Bacterial/blood , Burkholderia mallei/immunology , Equidae , Glanders/blood , Glanders/microbiology , Horse Diseases/blood , Horse Diseases/microbiology , Horses , Mice , Sensitivity and Specificity
2.
Equine Vet J ; 53(4): 826-833, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33011979

ABSTRACT

BACKGROUND: African horse sickness (AHS) is a devastating viral disease of equids that was first recorded in 1327. Currently, prevention and control of the disease are based on attenuated vaccines and midge control. It has been shown that attenuated Orbivirus vaccines are not always safe as they may reverse to virulence. OBJECTIVES: In the Emirate of Dubai, a vaccination experiment was carried out with an inactivated AHS vaccine produced at the Central Veterinary Research Laboratory (CVRL), Dubai, UAE to investigate the humoral antibody response of AHS-naïve horses to this vaccine. Our vaccination experiment was performed to establish an AHS vaccine bank in the UAE to protect horses from the disease in case of an outbreak. Therefore, CVRL established an inactivated AHS vaccine containing all nine serotypes which induce high neutralising antibodies. STUDY DESIGN: A total of 10 horses kept in a desert isolation area were subcutaneously and intramuscularly vaccinated with an inactivated vaccine containing all nine AHS serotypes previously isolated from Kenyan horse fatalities. Primary immunisation was followed by two booster immunisations 4 weeks and 6 months apart. After 13 months, an annual booster was administered. METHODS: Blood samples were regularly withdrawn for ELISA and virus neutralisation testing. Additionally, EDTA blood was tested every second day for 14 days post each vaccination for the presence of AHS virus or its RNA. RESULTS: Results show that ELISA and virus neutralising antibodies appeared after the first booster, declined after 4-6 months and therefore three vaccinations and an annual vaccination are necessary to achieve high protective virus neutralising antibodies. MAIN LIMITATIONS: No challenge infection was carried out due to the lack of a safe facility in the UAE. CONCLUSION: Before more advanced AHS vaccines become a reality, inactivated vaccines containing all nine serotypes should be used as they produce high ELISA and neutralising antibodies.


Subject(s)
African Horse Sickness Virus , African Horse Sickness , Horse Diseases , Viral Vaccines , African Horse Sickness/prevention & control , Animals , Antibodies, Neutralizing , Antibodies, Viral , Antibody Formation , Horse Diseases/prevention & control , Horses , Kenya , Serogroup , Vaccination/veterinary , Vaccines, Inactivated
3.
Viruses ; 11(12)2019 12 08.
Article in English | MEDLINE | ID: mdl-31817946

ABSTRACT

Peste-des-petits-ruminants virus (PPRV) causes a severe respiratory disease in small ruminants. The possible impact of different atypical host species in the spread and planed worldwide eradication of PPRV remains to be clarified. Recent transmission trials with the virulent PPRV lineage IV (LIV)-strain Kurdistan/2011 revealed that pigs and wild boar are possible sources of PPRV-infection. We therefore investigated the role of cattle, llamas, alpacas, and dromedary camels in transmission trials using the Kurdistan/2011 strain for intranasal infection and integrated a literature review for a proper evaluation of their host traits and role in PPRV-transmission. Cattle and camelids developed no clinical signs, no viremia, shed no or only low PPRV-RNA loads in swab samples and did not transmit any PPRV to the contact animals. The distribution of PPRV-RNA or antigen in lymphoid organs was similar in cattle and camelids although generally lower compared to suids and small ruminants. In the typical small ruminant hosts, the tissue tropism, pathogenesis and disease expression after PPRV-infection is associated with infection of immune and epithelial cells via SLAM and nectin-4 receptors, respectively. We therefore suggest a different pathogenesis in cattle and camelids and both as dead-end hosts for PPRV.


Subject(s)
Camelus/virology , Host Specificity , Host-Pathogen Interactions , Peste-des-Petits-Ruminants/virology , Peste-des-petits-ruminants virus/physiology , Animals , Antibodies, Viral/blood , Antibodies, Viral/immunology , Biomarkers , Biopsy , Cattle , Female , Hematologic Tests , Immunohistochemistry , Male , Peste-des-Petits-Ruminants/blood , Peste-des-Petits-Ruminants/pathology
4.
Vet Ital ; 55(3): 261-267, 2019 Sep 30.
Article in English | MEDLINE | ID: mdl-31599551

ABSTRACT

Six horses were challenged experimentally with a strain of Burkholderia pseudomallei isolated from a fatal case of the infection in a dromedary camel years earlier in the Emirate of Dubai. Three horses were inoculated subcutaneously and in 3 the bacterium was administered by the oral route. Four of the horses became serologically positive based on reactions to one or more of the OIE described tests for glanders. B. pseudomallei was re-isolated from the 4 serological positive horses. Only one of the subcutaneously infected horses, developed fever for 3 days. The white blood cell values and the neutrophil counts were also elevated. The study confirmed that existing serological test for diagnosing glanders cannot differentiate between glanders and melioidosis in horses.


Subject(s)
Burkholderia pseudomallei/physiology , Diagnostic Tests, Routine/veterinary , Horse Diseases/diagnosis , Melioidosis/veterinary , Animals , Antibodies, Bacterial/blood , Diagnostic Tests, Routine/instrumentation , Female , Glanders/diagnosis , Horse Diseases/microbiology , Horses , Male , Melioidosis/diagnosis , Melioidosis/microbiology , United Arab Emirates
5.
Mycoses ; 61(8): 600-609, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29611232

ABSTRACT

Aspergillosis in falcons may be associated with high mortality and difficulties in clinical and laboratory diagnosis. We previously cloned an immunogenic protein, Afmp1p, in Aspergillus fumigatus and showed that anti-Afmp1p antibodies were present in human patients with A. fumigatus infections. In this study, we hypothesise that a similar Afmp1p-based enzyme-linked immunosorbent assay (ELISA) could be applied to serodiagnose falcon aspergillosis. A specific polyclonal antibody was first generated to detect falcon serum IgY. Horseradish peroxidase-conjugate of this antibody was then used to measure anti-Afmp1p antibodies in sera collected from falcons experimentally infected with A. fumigatus, and the performance of the Afmp1p-based ELISA was evaluated using sera from healthy falcons and falcons with documented A. fumigatus infections. All four experimentally infected falcons developed culture- and histology-proven invasive aspergillosis. Anti-Afmp1p antibodies were detected in their sera. For the Afmp1p-based ELISA, the mean ± SD OD450 nm using sera from 129 healthy falcons was 0.186 ± 0.073. Receiver operating characteristics curve analysis showed an absorbance cut-off value of 0.407. One negative serum gave an absorbance outside the normal range, giving a specificity of 99.2%. For the 12 sera from falcons with confirmed aspergillosis, nine gave absorbance values ≥ cut-off, giving a sensitivity of 75%. The Afmp1p-based ELISA is useful for serodiagnosis of falcons with aspergillosis.


Subject(s)
Antibodies, Fungal/blood , Antigens, Fungal/immunology , Aspergillosis/veterinary , Bird Diseases/diagnosis , Enzyme-Linked Immunosorbent Assay/methods , Falconiformes , Membrane Glycoproteins/immunology , Serologic Tests/methods , Animals , Aspergillosis/diagnosis , ROC Curve , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...